Pharmacogenomic (PGx) testing allows healthcare providers to make more informed, evidence-based decisions for their patients. To take advantage of this new clinical tool, we’ve recently seen several large healthcare

For more than a decade, a robust body of evidence has progressively unveiled drug-genome interactions with important implications for health. Yet doctors and many health-care systems have been slow to implement

The latest CPIC 2019 conference drew a diverse community of more than 200 attendees. The participants were mostly pharmacists (89) and laboratory professionals (102), confirming that successful implementations of

In 2018, 59 new medications earned FDA approval. Multigene pharmacogenomics (PGx) panels can safely prescribe three of these new drugs to prevent unnecessary toxicities and drug-genome interactions. A decade ago, few

When it comes to wide-scale adoption of pharmacogenomics (PGx) testing, reimbursement has been one of the industry’s biggest roadblocks. This is especially true when it comes to the preemptive testing model. While